Patients received pertuzumab/placebo at @ mg in cycle @ and @ mg in subsequent cycles , and trastuzumab at @ mg/kg in cycle @ and @ mg/kg in subsequent cycles ; docetaxel was initiated at @ mg/m ( @ ) .